Dbp5 Inhibitors
Dbp5 inhibitors are a class of chemical compounds that specifically target and inhibit the function of Dbp5, a DEAD-box RNA helicase, also known as DDX19, which plays a crucial role in the export of mRNA from the nucleus to the cytoplasm. Dbp5 is involved in remodeling ribonucleoprotein complexes (RNPs) by unwinding RNA secondary structures and displacing proteins, which facilitates the proper export of mRNA through the nuclear pore complex. This helicase activity is critical for mRNA processing, translation, and ultimately gene expression. By inhibiting Dbp5, researchers can investigate its essential role in mRNA export, the dynamics of nuclear-cytoplasmic transport, and how these processes are tightly regulated in the cell.
The mechanism of action for Dbp5 inhibitors generally involves blocking the ATPase activity or RNA binding domains of the protein, preventing it from remodeling RNPs and disrupting its function in mRNA export. These inhibitors might bind to the ATP-binding site, rendering the helicase inactive, or they could interfere with the interaction between Dbp5 and its co-factors, such as Gle1, which is essential for Dbp5's activation at the nuclear pore. Structurally, Dbp5 inhibitors are designed to mimic key substrates or transition states of the helicase, allowing them to compete with natural ligands or bind to specific regions of the protein that are critical for its activity. By studying Dbp5 inhibitors, researchers gain valuable insights into the regulation of mRNA export, the role of RNA helicases in gene expression, and how disruptions in these processes can affect cellular homeostasis and protein synthesis. These inhibitors provide an essential tool for understanding the broader biological implications of RNA helicases in cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could decrease Dbp5 expression by inhibiting the mTOR pathway, leading to a reduction in cap-dependent mRNA translation which is necessary for Dbp5 protein synthesis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil might reduce Dbp5 levels by causing nucleotide imbalances, leading to DNA damage responses that downregulate non-essential gene expression, including Dbp5. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may downregulate Dbp5 expression through its action as an activator of SIRT1, leading to deacetylation of histones and tighter DNA packing, thus decreasing transcription of certain genes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could decrease Dbp5 expression by inhibiting NF-kB signaling, which may be involved in the transcriptional initiation of Dbp5 gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a derivative of vitamin A, retinoic acid may reduce Dbp5 expression by binding to retinoic acid receptors that alter the transcription of genes, including those involved in RNA processing. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 could inhibit Dbp5 expression by blocking the PI3K/Akt pathway, which is often involved in the transcriptional regulation of various genes, potentially leading to reduced mRNA levels of Dbp5. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This inhibitor could decrease Dbp5 expression by blocking JNK signaling, which may play a role in the cellular stress response that can lead to selective downregulation of gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 may inhibit Dbp5 expression by obstructing the p38 MAPK pathway, which could be involved in the response to cytokines that otherwise promote the expression of RNA processing genes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may reduce Dbp5 expression by inhibiting the MEK/ERK pathway, potentially leading to changes in transcriptional dynamics for genes involved in mRNA export and processing. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin could inhibit Dbp5 expression by destabilizing client proteins of HSP90 that are involved in the stabilization of transcription complexes necessary for Dbp5 gene transcription. | ||||||